Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Alteogen received a final decision of non-designation as an unfaithful disclosure corporation as mitigating factors were accepted following prior notices regarding two disclosure reversals (cancellation of subsidiary merger and stock acquisition).
📊 [Key Disclosure Details & Financial Highlights]
- Advance Notice Details of Unfaithful Disclosure Corporation:
- Type of Unfaithful Disclosure: Disclosure Reversal (2 cases)
- Specific Details:
- Revocation of Merger Decision (Major Management Matter of Subsidiary)
- Revocation of Decision on Acquisition of Shares and Investment Certificates of Other Corporations
- Original Disclosure Date: 2024-11-07
- Revocation Disclosure Date: 2024-11-29
- Advance Notice Date: 2024-12-24
- Details of Non-Designation Decision:
- Decision Date: 2025-01-15
- Final Result: Non-designation (Postponement of designation: N/A)
- Reason for Non-Designation: Non-designation due to mitigating factors
- Governing Regulations: Articles 28 and 32 of the KOSDAQ Market Disclosure Regulations
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Finalization of Non-Designation Status and Review of Corporate Disclosure Status
This filing informs that the advance notice regarding an unfaithful disclosure designation caused by subsidiary merger and share acquisition cancellations was closed with a final non-designation decision due to mitigating reasons. Verifying that the non-designation decision remains officially maintained is important to understand the company’s disclosure compliance record. Further related information can be reviewed in upcoming periodic reports (quarterly, half-yearly, or annual business reports).
📢 Disclaimer & Source Information
Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For inquiries regarding regulatory compliance or copyright requests, please contact ksb220805@gmail.com.
